Extemporaneous compounding: The end of the road?

Dermatologic Clinics

Volumn 16, Issue 2, 1998, Pages 321-327

  Ling, M R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACICLOVIR; CLINDAMYCIN;

DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; LEGAL ASPECT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN MANIFESTATION; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 0031947329     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70014-0     Document Type: Article

References (14)

1. B.W. Barry Formulation of dermatologic vehicles Dermatological Formulations: Percutaneous Absorption 1983 Marcel Dekker, Inc. New York 296
2. B.W. Barry Rheology of dermatological vehicles Formulation of Dermatological Vehicles 1983 Marcel Dekker, Inc. New York and Basel 351
3. B.W. Barry The clinical relevance of in vitro investigations for percutaneous absorption R. Marks Topics in Topicals 1985 MTP Press Ltd. Lancaster 91
4. W.E. Fassett J.L. Fink Extemporaneous compounding: Promotional and legal aspects Am Pharmacy 8 1984 62
5. Food and Drug Administration Title 21 Code of Federal Regulations. Part 21—Current good manufacturing practice for finished pharmaceuticals. United States.
6. T.J. Franz On the bioavailability of topical formulations of clindamycin hydrochloride J Am Acad Dermatol 1 1983 66
7. J.E. Fulton A. Farzad-Bakshandeh S. Bradley Studies on the mechanism of action of topical benzoyl peroxide and vitamin A acid in acne vulgaris J Cut Pathol 1 1974 191
8. K.M. Kilbourne R.M. Philen M.L. Kamb Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome J Rheum 46 1996 81
9. L. Krochmal B. Patel Topical product design and extemporaneous compounding in dermatology Adv Dermatol 7 1992 231
10. L. Krochmal J.C.T. Wang B. Patel Topical corticosteroid compounding: Effects on physiochemical stability and skin penetration rate J Am Acad Dermatol 21 1989 979
11. M. Lebwohl Pitfalls in the use of dovonex Psoriasis Forum 1 1995 1
12. G.E. Parry P. Dunn V.P. Shah Acyclovir bioavailability in human skin J Invest Dermatol 98 1992 856
13. G.W. Raborn W.T. McGaw M. Grace Treatment of herpes labialis with acyclovir: Review of three clinical trials Am J Med 85 1988 39
14. J.R. Sabourin Selecting a preservative for creams and lotions Cosmet Toiletries 101 1986 93